Related Articles
ONDANSETRON VERSUS METOCLOPRAMIDE IN THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING - A METAANALYSIS
Comparison between the antiemetic effects of palonosetron and granisetron in breast cancer patients treated with anthracycline‑based regimens
A phase II clinical trial of palonosetron for the management of delayed vomiting in gynecological cancer patients receiving paclitaxel/carboplatin therapy
Difference in the emetic control among highly emetogenic chemotherapy regimens: Implementation for appropriate use of aprepitant
Single agent vinorelbine in the treatment of unresectable lung metastases from colorectal cancer